Utilization Patterns of Pulmicort in Real Life Practice

Utilization Patterns of Pulmicort HFA in Real Life Practice

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00660569

Enrollment

260

Registered

2008-04-17

Start date

2008-01-31

Completion date

2009-02-28

Last updated

2010-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

asthma treatment, utilization, real life practice

Brief summary

The purpose of this study is to identify the potential issues during short and mid term utilization of Pulmicort hydro fluoroaklane (HFA) pressurized metered-dose inhaler (pMDI)and describe associated factors.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Asthmatic patients with a diagnose of at least 12 months of duration before study inclusion * Patients previously treated with Pulmicort CFC who have changed their treatment to Pulmicort HFA

Exclusion criteria

* Disability that, from investigator point of view, prevent from complying the follow up schedule * To have participated in any clinical study in the past 6 months

Countries

Spain

Outcome results